Skip to main content
Thor Medical ASA logo

Thor Medical ASA — Investor Relations & Filings

Ticker · NANOV ISIN · NO0010597883 LEI · 5967007LIEEXZXG6DK30 OL Manufacturing
Open in API
Filings indexed 106 across all filing types
Latest filing 2025-06-25 Capital/Financing Update
Country NO Norway
Listing OL NANOV

About Thor Medical ASA

https://www.thormedical.com/

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Recent filings

Filing Released Lang Actions
Thor Medical ASA: Registration of national prospectus and launch of subsequent offering - Attachment: Download announcement as PDF.pdf
Capital/Financing Update Classification · 98% confidence The document is an announcement from Thor Medical ASA dated June 25, 2025, detailing the registration of a national prospectus and the launch of a subsequent offering of new shares. It explicitly mentions the subscription period, record date, subscription rights, and expected payment/registration dates related to a capital raise. The text also states that the Prospectus has been registered and is available for download, but the document itself is the announcement describing the offering mechanics and the availability of the prospectus, not the full financial report (10-K, IR) or the presentation (IP). This activity—announcing a share offering, subscription details, and the associated prospectus registration—falls under financing activities. The most appropriate category is 'Capital/Financing Update' (CAP). It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a Report Publication Announcement (RPA) because it contains substantial details about the offering itself, rather than just announcing that a report is available.
2025-06-25 English
Thor Medical ASA: Registration of national prospectus and launch of subsequent offering
Report Publication Announcement Classification · 95% confidence The document is an announcement titled "Thor Medical ASA: Registration of national prospectus and launch of subsequent offering." It details the launch of a subsequent offering of shares, including subscription periods, rights allocation, and expected timelines for registration and payment. Crucially, it mentions that a Prospectus has been registered and provides links to download the announcement as a PDF. This structure—announcing a specific corporate action (share offering) and referencing the publication of a formal document (Prospectus) while being relatively short and focused on the announcement itself—strongly suggests it is a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the core action is announcing the publication/registration of the prospectus related to a capital raise, and it is not the full prospectus or a standard financial report (like 10-K or IR), RPA is the most fitting category, as it announces the publication of other required documents. Given the context of a stock exchange announcement regarding a share offering, it also fits the general regulatory announcement category (RNS), but RPA is more specific to announcing the release of a report/prospectus.
2025-06-25 English
Thor Medical ASA: Ex. right to participate in subsequent offering today - Attachment: Download announcement as PDF.pdf
Share Issue/Capital Change Classification · 99% confidence The document is a short announcement (1435 characters) from Thor Medical ASA dated June 19, 2025, regarding the ex-date for the right to participate in a subsequent offering of shares. It references a prior announcement and states that the shares will trade exclusive of this right starting today. This is a specific corporate action related to capital structure/share issuance, but it is presented as a brief regulatory update published according to Euronext Oslo Børs obligations. Since it is a short announcement detailing a specific event (ex-date related to a share offering) rather than the full details of a capital change (SHA) or a general regulatory filing (RNS), it fits best under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS). Given the focus on the 'ex date' related to a 'subsequent offering of shares,' it directly relates to capital structure changes. However, the text is very brief and functions primarily as a notification of a market event based on a prior offering announcement. It is not a full Share Issue announcement (SHA) or a general regulatory filing (RNS). It is most closely aligned with Capital/Financing Update (CAP) as it concerns the mechanics of a share offering, or potentially a Regulatory Filing (RNS) as a general market notice. Given the specific nature of the share rights being traded, CAP is a strong candidate, but RNS is often used for these short, mandatory exchange notices. Since it is a notice about the mechanics of a share offering, I will classify it as CAP, as it is more specific than RNS, but I acknowledge the short nature might suggest RPA/RNS if it were just linking to another document. Since it contains the core information (Ex. Date: 19 June 2025) and is published under continuing obligations, CAP is the most appropriate specific category for an update on a financing/share activity.
2025-06-19 English
Thor Medical ASA: Ex. right to participate in subsequent offering today
Share Issue/Capital Change Classification · 98% confidence The document is a short announcement (1539 characters) from Thor Medical ASA regarding the ex-date for the right to participate in a subsequent share offering. It references a prior announcement and explicitly states that shares will trade exclusive of this right starting today. This relates directly to changes in the company's capital structure or share issuance activities. The most fitting category is 'Share Issue/Capital Change' (SHA), as it deals with the mechanics of a new share offering. It is not a general regulatory filing (RNS) because it fits a more specific category, and it is not an announcement of a report (RPA) because it is providing substantive news about a financing event, not just announcing the publication of a separate report.
2025-06-19 English
Thor Medical ASA: Key information relating to potential subsequent offering - Attachment: Download announcement as PDF.pdf
Capital/Financing Update Classification · 98% confidence The document is an announcement from Thor Medical ASA dated June 18, 2025, detailing key information regarding a potential subsequent share offering following a private placement. It explicitly outlines the terms, dates (record date, last day including right), maximum number of shares, and subscription price. This content directly relates to fundraising, capital structure changes, and the issuance of new shares. This aligns best with the 'Capital/Financing Update' (CAP) definition. Although it involves share issuance (which could suggest SHA), the primary focus is the financing mechanism (subsequent offering based on rights) following a capital raise, making CAP the most precise fit. It is not a full report (10-K, IR) nor a simple announcement of a report (RPA), but the substance of a financing event.
2025-06-18 English
Thor Medical ASA: Key information relating to potential subsequent offering
Capital/Financing Update Classification · 98% confidence The document is an announcement from Thor Medical ASA detailing key information regarding a potential subsequent share offering, including dates, subscription price, and maximum number of shares. It explicitly mentions that the formal resolution will be made by the board and that the offering will be subject to registration of a national prospectus. The text is structured as a regulatory disclosure ('Additional regulated information required to be disclosed under the laws of a member state') and concerns capital raising activities (share offering). This aligns best with the 'Capital/Financing Update' category (CAP), as it is a specific announcement about a planned financing event, rather than a general regulatory filing (RNS) or a report itself.
2025-06-18 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.